SS Innovations Wins 2026 Surgical Robotics Outstanding Company Award

SS Innovations International (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, recognizing excellence in innovation, commercial success, industry leadership, and positive societal impact. The award highlights the growing adoption of the company's SSi Mantra surgical robotic system, which is gaining traction for its advanced technology, user-friendly design, training capabilities, and cost efficiency. As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries, and 212 pediatric surgeries. Approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries.

The company's vision is to make robotic surgery affordable and accessible globally, with its product range including the SSi Mantra surgical robotic system and the SSi Mudra surgical instruments. These tools support a variety of procedures, including cardiac surgery. Headquartered in India but an American company, SS Innovations plans to expand its global presence with its technologically advanced, user-friendly, and cost-effective solutions. The full press release is available at https://ibn.fm/XWdRe.

This recognition underscores SS Innovations' commitment to democratizing surgical robotics, potentially transforming healthcare by lowering costs and increasing access to advanced surgical care. The company's achievements in telesurgery and pediatric cases demonstrate its broad applicability and potential to improve outcomes worldwide.